<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF
THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER
SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 33-78022
------------------
FUTUREBIOTICS, INC.
--------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
145 Ricefield Lane, Hauppauge, New York 11788 (631) 273-2630
--------------------------------------------------------------------------------
(Address, including zip code, and telephone number, including area code,
of registrant's principal executive offices)
Common Stock, par value $.0001 per share ("Common Stock");
and
Preferred Stock, par value $.0001 per share ("Preferred Stock")
--------------------------------------------------------------------------------
(Title of each class of securities covered by this Form)
None
--------------------------------------------------------------------------------
(Title of all other classes of securities for which a duty to file
reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1)(i) /X/ Rule 12h-3(b)(1)(i) / /
Rule 12g-4(a)(1)(ii) / / Rule 12h-3(b)(1)(ii) / /
Rule 12g-4(a)(2)(i) / / Rule 12h-3(b)(2)(i) / /
Rule 12g-4(a)(2)(ii) / / Rule 12h-3(b)(2)(ii) / /
Rule 15(d) / /
Approximate number of holders of record as of the certification or
notice date: 186
----------------------------
Pursuant to the requirements of the Securities Exchange Act of 1934
Futurebiotics, Inc. has caused this certification/notice to be signed on its
behalf by the undersigned duly authorized person.
Date: 1/17/01 By: /s/ Reginald Spinello
---------------------------- --------------------------------
Reginald Spinello, President
